Brunello, N.; den Boer, J. A.; Judd, L. L.; Kasper, S.; Kelsey, J. E.; Lader, M.; Lecrubier, Y.; Lepine, J. P.; Lydiard, R. B.; Mendlewicz, J. et al.; Montgomery, S. A.; Racagni, G.; Stein, M. B.; Wittchen, H.-U.: Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. Journal of Affective Disorders 60, pp. 61 - 74 (2000)

Dluzen, D. E.; Muraoka, S.; Engelmann, M.; Ebner, K.; Landgraf, R.: Oxytocin induces preservation of social recognition in male rats activating α-adrenoceptors of the olfactory bulb. European Journal of Neuroscience 12, pp. 760 - 766 (2000)

Do, K. Q.; Trabesinger, A.; Kirsten-Krüger, M.; Lauer, C. J.; Dydak, U.; Hell, D.; Holsboer, F.; Boesiger, P.; Cuénod, M.: Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. European Journal of Neuroscience 12, pp. 3721 - 3728 (2000)

Ebner, K.; Wotjak, C. T.; Landgraf, R.; Engelmann, M.: A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats. Brain Research 872, pp. 87 - 92 (2000)

Engelhard, K.; Werner, C.; Lu, H.; Möllenberg, O.; Zieglgänsberger, W.; Kochs, E.: Der neuroprotektive Einfluss des Glutamat-Antagonisten Acamprosat nach experimenteller Ischämie. Ein Vergleich mit dem Lipidperoxidase-Inhibitor U-101033 E. Anaesthesist 49, pp. 816 - 821 (2000)

Engelmann, M.; Wotjak, C. T.; Ebner, K.; Landgraf, R.: Behavioural impact of intraseptally released vasopressin and oxytocin rats. Experimental Physiology 85 S, pp. 125 S - 130 S (2000)

Friess, E.; Schiffelholz, T.; Steckler, T.; Steiger, A.: Dehydroepiandrosterone - a neurosteroid. European Journal of Clinical Investigation 30 (Suppl. 3), pp. 46 - 50 (2000)

Goodenough, S.; Engert, S.; Behl, C.: Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neuroscience Letters 296, pp. 49 - 52 (2000)

Gössl, C.; Auer, D. P.; Fahrmeir, L.: Dynamic models in fMRI. Magnetic Resonance in Medicine 43, pp. 72 - 81 (2000)

Greeve, I.; Hermans-Borgmeyer, I.; Brellinger, C.; Kasper, D.; Gomez-Isla, T.; Behl, C.; Levkau, B.; Nitsch, R. M.: The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. Journal of Neuroscience 20, pp. 7345 - 7352 (2000)

Haack, M.; Reichenberg, A.; Kraus, T.; Schuld, A.; Yirmiya, R.; Pollmächer, T.: Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men. Cytokine 12, pp. 694 - 698 (2000)

Hapfelmeier, G.; Zieglgänsberger, W.; Haseneder, R.; Schneck, H.; Kochs, E.: Nitrous oxide and xenon increase the efficacy of GABA at recombinant mammalian GABA_A receptors. Anesthesia and Analgesia 91, pp. 1542 - 1549 (2000)

Hatzinger, M.; Wotjak, C. T.; Naruo, T.; Simchen, R.; Keck, M. E.; Landgraf, R.; Holsboer, F.; Neumann, I. D.: Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats. Journal of Endocrinology 164, pp. 197 - 205 (2000)

Henniger, M. S. H.; Ohl, F.; Hölter, S. M.; Weißenbacher, P.; Toschi, N.; Lörscher, P.; Wigger, A.; Spanagel, R.; Landgraf, R.: Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour. Behavioural Brain Research 111, pp. 153 - 163 (2000)

Hermann, B.; Landgraf, R.; Keck, M. E.; Wigger, A.; Morrow, A. L.; Ströhle, A.; Holsboer, F.; Rupprecht, R.: Pharmacological characterisation of cortical gamma-aminobutyric acid type A (GABA-A) receptors in two wistar rat lines selectively bred for high- and low-anxiety-treated behavior. World Journal of Biological Psychiatry 1, pp. 137 - 143 (2000)

Herr, A. S.; Wochnik, G. M.; Rosenhagen, M. C.; Holsboer, F.; Rein, T.: Rifampicin is not an activator of glucocorticoid receptor. Molecular Pharmacology 57, pp. 732 - 737 (2000)

Heuser, I.; Deuschle, M.; Weber, B.; Stalla, G. K.; Holsboer, F.: Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 25, pp. 513 - 518 (2000)

Hinze-Selch, D.; Deuschle, M.; Weber, B.; Heuser, I.; Pollmächer, T.: Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight. Psychopharmacology 149, pp. 163 - 169 (2000)

Hinze-Selch, D.; Weber, M. M.; Zimmermann, U.; Pollmächer, T.: Die Thiaminbehandlung in der Psychiatrie und Neurologie. Fortschritte der Neurologie/Psychiatrie 68, pp. 113 - 120 (2000)

Höfler, M.; Wittchen, H.-U.: Why do primary care doctors diagnose depression when diagnostic criteria are not met? International Journal of Methods in Psychiatric Research 9, pp. 110 - 120 (2000)